4-Hydroxybenzoic acid (4‑HBA) is a benzoic acid derivative in the class of phenolic organic acids. It appears widely in plants and foods and is produced or transformed by gut microbes during breakdown of aromatic compounds and polyphenols. Laboratories commonly measure 4‑HBA in urine as an accessible readout of aromatic metabolism. Biochemically, 4‑HBA participates as an intermediate in microbial and plant pathways and is a known precursor in coenzyme Q (ubiquinone) biosynthesis in some organisms. Clinically and in research, urinary 4‑HBA has been used as an organic acid marker to help map microbial metabolism, dietary processing of phenolics, and aspects of host–microbe interaction relevant to detoxification and redox chemistry.

Elevated urinary 4‑HBA may reflect increased microbial production or altered gut ecology that favors aromatic compound breakdown, higher intake or absorption of phenolic foods, or shifts in how the body conjugates and clears phenolic metabolites. It can also occur when downstream metabolic steps are slowed, leading to greater excretion. Interpretation is context dependent and should account for diet, medications, and other organic acid patterns on the full panel. Lower-than-expected 4‑HBA levels may indicate reduced microbial generation of this metabolite, limited dietary substrate availability, or accelerated downstream metabolism and clearance. Low levels can also arise when microbial diversity or activity that produces phenolic acids is reduced. As with high values, clinical meaning is clarified by comparing this marker with other Cellular Zoomer results and clinical information.

Included in the Cellular Zoomer because 4‑HBA links microbial aromatic metabolism with host detox and redox pathways. It helps evaluate whether microbial byproducts or altered phenolic processing are contributing to oxidative load or metabolic strain, offering one piece of the integrated cellular resilience picture used to personalize care.